Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VALacyclovir In Delaying Antiretroviral Treatment Entry

NCT00860977 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00860977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VALacyclovir In Delaying Antiretroviral Treatment Entry
Lead sponsor
University Health Network, Toronto
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
August 31, 2015
Enrollment
202 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex type ii, hiv infection, hiv infections